We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 9,301 results
  1. IR808@MnO nano-near infrared fluorescent dye’s diagnostic value for malignant pleural effusion

    Background

    Malignant pleural effusion is mostly a complication of advanced malignant tumors. However, the cancer markers such as carbohydrate antigen...

    **aoqiong Wang, **ngya Yan, ... Yongsheng Wang in Respiratory Research
    Article Open access 09 January 2024
  2. Malignant pleural effusion: current understanding and therapeutic approach

    Malignant pleural effusion (MPE) is a common complication of thoracic and extrathoracic malignancies and is associated with high mortality and...

    Francesca Gonnelli, Wafa Hassan, ... Federico Mei in Respiratory Research
    Article Open access 19 January 2024
  3. Diagnostic value of SHOX2, RASSF1A gene methylation combined with CEA level detection in malignant pleural effusion

    Aim

    To investigate the diagnostic value of combined detection of SHOX2 and RASSF1A gene methylation with carcinoembryonic antigen (CEA) level in...

    Shaosen Chen, Kunlun Huang, ... Peicun Hu in BMC Pulmonary Medicine
    Article Open access 08 May 2023
  4. Diagnostic value of immune-related biomarker FAM83A in differentiating malignant from benign pleural effusion in lung adenocarcinoma

    Background

    Malignant pleural effusion (MPE) is frequently observed in patients with advanced lung adenocarcinoma (LUAD). Pleural fluid cytology is a...

    Hangfeng Liu, Jia Yao, ... Shuanghua Cheng in Discover Oncology
    Article Open access 24 June 2024
  5. Added value of 40 keV virtual monoenergetic images for diagnosing malignant pleural effusion on chest CT

    Objective

    This study aimed to evaluate the added value of 40 keV virtual mono-energetic images (VMIs) obtained from dual-layer detector CT (DLCT) for...

    Nahyeon Kim, Kyungsoo Bae, ... Kyung Nyeo Jeon in Japanese Journal of Radiology
    Article 03 May 2024
  6. Development and validation of a radiomics nomogram for diagnosis of malignant pleural effusion

    Objective

    We aimed to develop a radiomics nomogram based on computed tomography (CT) scan features and high-throughput radiomics features for...

    Mingzhu Wei, Ya** Zhang, ... Zhenhua Zhao in Discover Oncology
    Article Open access 24 November 2023
  7. Age affects the diagnostic accuracy of the cancer ratio for malignant pleural effusion

    Background and objective

    Cancer ratio (CR), which is defined as serum lactate dehydrogenase (LDH) to pleural fluid adenosine deaminase (ADA) ratio,...

    **-Hong Huang, Hong Chen, ... Ting-Wang Jiang in BMC Pulmonary Medicine
    Article Open access 07 June 2023
  8. Management of malignant pleural effusion in Italian clinical practice: a nationwide survey

    Background

    Pleural disease (PD), particularly malignant pleural effusion (MPE), is a common cause of hospital admission and its prevalence is rising...

    Federico Mei, Mario Tamburrini, ... Giampietro Marchetti in BMC Pulmonary Medicine
    Article Open access 10 July 2023
  9. Pleural fluid adenosine deaminase to serum C-reactive protein ratio for diagnosing tuberculous pleural effusion

    Background

    Tuberculous pleural effusion (TPE) and malignant pleural effusion (MPE) may occasionally show similar cytological and biochemical picture...

    Mohammad Fazle Rabbi, Mushfiq Newaz Ahmed, ... Mohammad Azmain Iktidar in BMC Pulmonary Medicine
    Article Open access 15 September 2023
  10. Clinical significance of pleural fluid lactate dehydrogenase/adenosine deaminase ratio in the diagnosis of tuberculous pleural effusion

    Background

    Pleural fluid is one of the common complications of thoracic diseases, and tuberculous pleural effusion (TPE) is the most common cause of...

    Tingting Zhao, Jianhua Zhang, ... Cheng Wang in BMC Pulmonary Medicine
    Article Open access 15 May 2024
  11. Efficacy of bevacizumab through an indwelling pleural catheter in non-small cell lung cancer patients with symptomatic malignant pleural effusion

    Background

    Several studies have indicated that intrapleural infusion of bevacizumab is an effective treatment for non-small cell lung cancer (NSCLC)...

    Hao Zeng, Yuanyuan Zhang, ... Yalun Li in BMC Pulmonary Medicine
    Article Open access 16 February 2024
  12. Biomarkers for distinguishing tuberculous pleural effusion from non-tuberculosis effusion: a retrospective study

    Background

    Pleural effusion (PE) is a common clinical feature that presents a diagnostic challenge for clinicians. In this retrospective study, we...

    Guo Fei, Mo Yijun, ... Liu Fang in BMC Infectious Diseases
    Article Open access 08 November 2023
  13. Efficacy and safety of intrapleural perfusion with hyperthermic chemotherapy for malignant pleural effusion: a meta-analysis

    Objective

    To evaluate the efficacy and safety of intrapleural perfusion with hyperthermic chemotherapy (IPHC) in treating malignant pleural effusion...

    Xue Pan, Zhichao Hou, ... **angnan Li in Journal of Cardiothoracic Surgery
    Article Open access 06 May 2024
  14. Transthoracic sonographic scores in evaluating the success of different scelerosing modalities in patients with malignant pleural effusion

    Background

    Malignant pleural effusions (MPE) mostly arises from metastases to the pleura from other sites. Management of malignant effusions aims to...

    Agmy Gamal, Mohamed F. Adam, ... Manal A. Mahmoud in The Egyptian Journal of Bronchology
    Article Open access 19 December 2022
  15. Complications of Palliative Interventions for Malignant Pleural Effusions

    Purpose of Review

    This review summarizes the potential complications of interventions performed for palliation of symptoms related to malignant...

    Audra J. Schwalk, Saadia A. Faiz, Carlos A. Jimenez in Current Pulmonology Reports
    Article 08 February 2024
  16. Can ultrasound shear wave elastography differentiate between malignant and benign pleural effusions?

    Background

    Malignant pleural effusion is a common and unfortunately serious condition that is related to life poor quality and mortality. The majority...

    Takeya Ahmed Taymour, Libya Saleh Wasel Mohamed, ... Mohammed Raafat Abd El-Mageed in Egyptian Journal of Radiology and Nuclear Medicine
    Article Open access 23 February 2024
  17. Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (±talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusion

    Introduction

    Malignant pleural effusions (MPEs) are common. MPE causes significant breathlessness and impairs quality of life. Indwelling pleural...

    Deirdre B. Fitzgerald, Calvin Sidhu, ... Y. C. Gary Lee in Trials
    Article Open access 27 June 2022
  18. Surgical intervention for non-small-cell lung cancer with minimal malignant pleural effusion

    Purpose

    We assessed the clinical significance of minimal malignant pleural effusion (MPE) using liquid-based cytology (LBC) and immunocytochemistry...

    Masashi Iwasaki, Masanori Shimomura, ... Masayoshi Inoue in Surgery Today
    Article 31 October 2022
  19. Subcutaneous octreotide therapy for malignant pleural effusion after pleurodesis with talc powder: a placebo-controlled, triple-blind, randomized trial

    Purpose

    In many cases, pleurodesis is the only treatment available for the treatment of malignant pleural effusion (MPE), and in the case of excessive...

    Reza Ershadi, Matin Vahedi, ... Shahab Rafieian in Supportive Care in Cancer
    Article 11 November 2022
  20. Evaluation of serum and pleural levels tumor M2-pyruvate kinase in lung cancer patients with pleural effusion

    Objective

    To evaluate the diagnostic value of tumor M2-pyruvate kinase (TuM2-PK) and carcinoembryonic antigen (CEA) levels in both pleural effusion...

    Tiantian Zhang, Wei Liu, ... Chunhua Xu in BMC Pulmonary Medicine
    Article Open access 10 August 2022
Did you find what you were looking for? Share feedback.